Commonwealth Equity Services’s Adial Pharmaceuticals ADIL Stock Holding History

Commonwealth Equity Services’s Portfolio ADIL Stock Details ADIL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-58	Closed	-$8K	–	3825
2023 Q2	$8K	Hold	58	–	–	﹤0.01%	3797
2023 Q1	$12	Hold	58	–	–	﹤0.01%	3708
2022 Q4	$7K	Hold	58	–	–	﹤0.01%	3665
2022 Q3	$12K	Hold	58	–	–	﹤0.01%	3611
2022 Q2	$48K	Hold	58	–	–	﹤0.01%	3489
2022 Q1	$73K	Hold	58	–	–	﹤0.01%	3539
2021 Q4	$98K	Hold	58	–	–	﹤0.01%	3457
2021 Q3	$156K	Buy	58 +12	+26%	+$25.1K	﹤0.01%	3340
2021 Q2	$74K	Buy	46 +11	+31%	+$16.7K	﹤0.01%	3434
2021 Q1	$53K	Buy	35 +18	+106%	+$27.2K	﹤0.01%	3330
2020 Q4	$18K	Hold	17	–	–	﹤0.01%	3177
2020 Q3	$23K	Hold	17	–	–	﹤0.01%	3003
2020 Q2	$14K	Hold	17	–	–	﹤0.01%	2923
2020 Q1	$13K	Hold	17	–	–	﹤0.01%	2777
2019 Q4	$25K	Hold	17	–	–	﹤0.01%	2844
2019 Q3	$16K	Buy	+17	New	+$18.1K	﹤0.01%	2805

Other funds holding ADIL

MCM

Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

AWM

Abound Wealth Management Franklin, Tennessee $504M AUM 23.73% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Commonwealth Equity Services's ADIL Position: Q3 2023 in Review

Commonwealth Equity Services sold out of Adial Pharmaceuticals (ADIL) in Q3 2023, closing a stake of 58 shares — an estimated $8K sold.

Commonwealth Equity Services first reported a position in ADIL in Q3 2019 and held it in 16 quarters. The position peaked at $156K in Q3 2021. 8 funds tracked by Wall St. Rank hold ADIL as of Q3 2023.

Commonwealth Equity Services reported no remaining Adial Pharmaceuticals position as of Q3 2023 after selling out during the quarter.
Commonwealth Equity Services sold 58 Adial Pharmaceuticals shares in Q3 2023, an estimated $8K.
Commonwealth Equity Services first reported a position in Adial Pharmaceuticals in Q3 2019 and held it in 16 quarters.
Commonwealth Equity Services's Adial Pharmaceuticals position peaked at $156K in Q3 2021.
8 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q3 2023.

Based on Commonwealth Equity Services's 13F filing for Q3 2023, filed 23 Oct 2023.